NCT01651130View on ClinicalTrials.gov

Carbetocin at Elective Cesarean Delivery Part 3

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

August 31, 2012

Study Completion Date

August 31, 2012

Conditions
Postpartum Hemorrhage
Interventions
DRUG

Carbetocin

Carbetocin IV, over 1 minute following delivery of the fetal head. Doses: 2, 5, 10, 15, 20 or 100mcg

Trial Locations (1)

M5G1X5

Mount Sinai Hospital, Toronto

All Listed Sponsors
lead

Samuel Lunenfeld Research Institute, Mount Sinai Hospital

OTHER

NCT01651130 - Carbetocin at Elective Cesarean Delivery Part 3 | Biotech Hunter | Biotech Hunter